Literature DB >> 12655055

The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment.

Karine Thiebault1, Laetitia Mazelin, Laurent Pays, Fabien Llambi, Marie-Odile Joly, Jean-Yves Scoazec, Jean-Christophe Saurin, Giovanni Romeo, Patrick Mehlen.   

Abstract

The three mammalian receptors UNC5H1, UNC5H2, and UNC5H3 (also named UNC5A, UNC5B, and UNC5C in human) that belong to the family of the netrin-1 receptors, UNC5H, were initially proposed as mediators of the chemorepulsive effect of netrin-1 on specific axons. However, they were also recently shown to act as dependence receptors. Such receptors induce apoptosis when unbound to their ligand. We show here that the expression of the human UNC5A, UNC5B, or UNC5C is down-regulated in multiple cancers including colorectal, breast, ovary, uterus, stomach, lung, or kidney cancers. In colorectal tumors, this down-regulation is associated with loss of heterozygosity occurring within UNC5A, UNC5B, and UNC5C genes but may also be partially related to epigenetic processes because histone deacetylase inhibitor increased UNC5C expression in various cancer cell lines. Moreover, sequencing of UNC5C gene in patients with colorectal tumors revealed the presence of missense mutations. The lossreduction of expression may be a crucial mechanism for tumorigenicity because the expression of UNC5H1, UNC5H2, or UNC5H3 inhibits tumor cell anchorage-independent growth and invasion. Moreover, these hallmarks of malignant transformation can be restored by netrin-1 addition or apoptosis inhibition. Hence, UNC5H1, UNC5H2, and UNC5H3 receptors may represent tumor suppressors that inhibit tumor extension outside the region of netrin-1 availability by inducing apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655055      PMCID: PMC153067          DOI: 10.1073/pnas.0738063100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Methylation-induced repression--belts, braces, and chromatin.

Authors:  A P Bird; A P Wolffe
Journal:  Cell       Date:  1999-11-24       Impact factor: 41.582

Review 2.  p75NTR and the concept of cellular dependence: seeing how the other half die.

Authors:  D E Bredesen; X Ye; A Tasinato; S Sperandio; J J Wang; N Assa-Munt; S Rabizadeh
Journal:  Cell Death Differ       Date:  1998-05       Impact factor: 15.828

3.  DNA methyltransferase is a downstream effector of cellular transformation triggered by simian virus 40 large T antigen.

Authors:  A Slack; N Cervoni; M Pinard; M Szyf
Journal:  J Biol Chem       Date:  1999-04-09       Impact factor: 5.157

4.  A ligand-gated association between cytoplasmic domains of UNC5 and DCC family receptors converts netrin-induced growth cone attraction to repulsion.

Authors:  K Hong; L Hinck; M Nishiyama; M M Poo; M Tessier-Lavigne; E Stein
Journal:  Cell       Date:  1999-06-25       Impact factor: 41.582

5.  Induction of apoptosis and G2/M cell cycle arrest by DCC.

Authors:  Y Q Chen; J T Hsieh; F Yao; B Fang; R C Pong; S C Cipriano; F Krepulat
Journal:  Oncogene       Date:  1999-04-29       Impact factor: 9.867

6.  TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1.

Authors:  R Fenrick; L Wang; J Nip; J M Amann; R J Rooney; J Walker-Daniels; H C Crawford; D L Hulboy; M S Kinch; L M Matrisian; S W Hiebert
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

7.  The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis.

Authors:  P Mehlen; S Rabizadeh; S J Snipas; N Assa-Munt; G S Salvesen; D E Bredesen
Journal:  Nature       Date:  1998-10-22       Impact factor: 49.962

8.  Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.

Authors:  W Hilgers; J J Song; M Haye; R R Hruban; S E Kern; E R Fearon
Journal:  Genes Chromosomes Cancer       Date:  2000-04       Impact factor: 5.006

9.  Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.

Authors:  E E Cameron; K E Bachman; S Myöhänen; J G Herman; S B Baylin
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

10.  Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung.

Authors:  S Petersen; M Aninat-Meyer; K Schlüns; K Gellert; M Dietel; I Petersen
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

View more
  68 in total

1.  The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer.

Authors:  L Shan; L Ambroisine; J Clark; R J Yáñez-Muñoz; G Fisher; S C Kudahetti; J Yang; S Kia; X Mao; A Fletcher; P Flohr; S Edwards; G Attard; J De-Bono; B D Young; C S Foster; V Reuter; H Moller; T D Oliver; D M Berney; P Scardino; J Cuzick; C S Cooper; Y-J Lu
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-02-23       Impact factor: 5.554

Review 2.  The role of UNC5C in Alzheimer's disease.

Authors:  Quan Li; Bai-Ling Wang; Fu-Rong Sun; Jie-Qiong Li; Xi-Peng Cao; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

Review 3.  Navigating breast cancer: axon guidance molecules as breast cancer tumor suppressors and oncogenes.

Authors:  Gwyndolen C Harburg; Lindsay Hinck
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-08-05       Impact factor: 2.673

4.  The dependence receptor UNC5H2 mediates apoptosis through DAP-kinase.

Authors:  Fabien Llambi; Filipe Calheiros Lourenço; Devrim Gozuacik; Catherine Guix; Laurent Pays; Gabriel Del Rio; Adi Kimchi; Patrick Mehlen
Journal:  EMBO J       Date:  2005-02-24       Impact factor: 11.598

5.  Evaluation of the colorectal cancer risk conferred by rare UNC5C alleles.

Authors:  Sébastien Küry; Céline Garrec; Fabrice Airaud; Flora Breheret; Virginie Guibert; Cécile Frenard; Shuo Jiao; Dominique Bonneau; Pascaline Berthet; Céline Bossard; Olivier Ingster; Estelle Cauchin; Stéphane Bezieau
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

6.  Clinical significance of UNC5B expression in bladder cancer.

Authors:  Jiao Liu; Zhe Zhang; Zhen-hua Li; Chui-Ze Kong
Journal:  Tumour Biol       Date:  2012-10-02

7.  Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.

Authors:  Neil V Morgan; Mark R Morris; Hakan Cangul; Diane Gleeson; Anna Straatman-Iwanowska; Nicholas Davies; Stephen Keenan; Shanaz Pasha; Fatimah Rahman; Dean Gentle; Maaike P G Vreeswijk; Peter Devilee; Margaret A Knowles; Serdar Ceylaner; Richard C Trembath; Carlos Dalence; Erol Kismet; Vedat Köseoğlu; Hans-Christoph Rossbach; Paul Gissen; David Tannahill; Eamonn R Maher
Journal:  PLoS Genet       Date:  2010-02-05       Impact factor: 5.917

8.  Distinct functions for netrin 1 in chicken and murine semicircular canal morphogenesis.

Authors:  Allison M Nishitani; Sho Ohta; Andrea R Yung; Tony Del Rio; Michael I Gordon; Victoria E Abraira; Evelyn C Avilés; Gary C Schoenwolf; Donna M Fekete; Lisa V Goodrich
Journal:  Development       Date:  2017-08-29       Impact factor: 6.868

9.  Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer.

Authors:  Julien Fitamant; Céline Guenebeaud; Marie-May Coissieux; Catherine Guix; Isabelle Treilleux; Jean-Yves Scoazec; Thomas Bachelot; Agnès Bernet; Patrick Mehlen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-19       Impact factor: 11.205

10.  Netrin-1 acts as a survival factor for aggressive neuroblastoma.

Authors:  Céline Delloye-Bourgeois; Julien Fitamant; Andrea Paradisi; David Cappellen; Setha Douc-Rasy; Marie-Anne Raquin; Dwayne Stupack; Akira Nakagawara; Raphaël Rousseau; Valérie Combaret; Alain Puisieux; Dominique Valteau-Couanet; Jean Bénard; Agnès Bernet; Patrick Mehlen
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.